
Amkor Technology, Inc.
- What it sells
- Advanced Products is 83% of revenue (fiscal year to Dec 2025), up from 77% two years earlier.
- Growing?
- Flat: revenue about the same as a year earlier (quarter ended Sep 2026); earnings per share up 98% over the last four quarters.
- Expensive?
- About usual: 15.0× trailing earnings; its five-year median is 16.8×. Priced 57% below the peer median of 34.8x.
- Analysts?
- 64% of 11 say buy; average 12-month target $66.00, 78% above today's price.
- Risky?
- Much swingier than most large companies: its price swung 81% over the past year (the S&P 500's 14%), and it fell as much as 67% since Nov 2021.
Amkor Technology, Inc. provides outsourced semiconductor assembly and test (OSAT) services, including packaging design/assembly and final test for integrated circuits.
More about Amkor Technology
Revenue is primarily generated from contract manufacturing services priced per unit and by package/test complexity/volume.
Market Position
Amkor is one of the largest global OSAT providers, competing on advanced packaging capabilities (e.g., S-SWIFT™ and S-Connect for chiplet/high-bandwidth integration) and a broad, multi-region manufacturing footprint. Differentiation is driven by scale, process know-how across many package formats, and customer qualification history in high-reliability end markets (e.g., automotive/compute).
Key Segments
Operations are generally organized around Packaging & Assembly and Test service lines, with a growing mix shift toward advanced packaging solutions (SiP/2.5D/3D, flip-chip, interposer/bridge solutions).
How has the stock done?
Over the past month AMKR fell 22.8%; the semiconductor ETF (SMH) fell 15.1% and the S&P 500 fell 2.7%.
Over the past six months AMKR fell 49.5%; the semiconductor ETF (SMH) fell 10.6% and the S&P 500 rose 2.6%.
Over the past year AMKR rose 7.7%; the semiconductor ETF (SMH) rose 41.1% and the S&P 500 rose 10.8%.
Over five years AMKR rose 59.3%; the semiconductor ETF (SMH) rose 233.3% and the S&P 500 rose 62.0%.
From Jun 22, 2026 to Nov 5, 2026, the deepest drop from a high since Nov 2021
How much the price swings in a year; the S&P 500's was 14%
When the S&P 500 moves 1%, the stock has moved about 3.4% the same way
Show the earnings releases
| Released | Quarter | Revenue | EPS vs estimate | Stock, day after | 5 days after |
|---|---|---|---|---|---|
| Oct 26, 2026 | ended Sep 2026 | $2.0B (0% vs a year earlier) | $0.76 vs $0.78 (missed) | +1.6% | −6.0% |
| Jul 27, 2026 | ended Jun 2026 | $1.9B (+26% vs a year earlier) | $0.70 vs $0.48 (beat) | −29.7% | −21.7% |
| Apr 27, 2026 | ended Mar 2026 | $1.7B (+27% vs a year earlier) | $0.33 vs $0.24 (beat) | −8.6% | −9.1% |
| Feb 9, 2026 | ended Dec 2025 | $1.9B (+16% vs a year earlier) | $0.69 vs $0.44 (beat) | +8.3% | −5.1% |
| Oct 27, 2025 | ended Sep 2025 | $2.0B (+7% vs a year earlier) | — | −1.9% | +15.5% |
| Jul 28, 2025 | ended Jun 2025 | $1.5B (+3% vs a year earlier) | — | +18.5% | +5.6% |
| Apr 28, 2025 | ended Mar 2025 | $1.3B (−3% vs a year earlier) | — | −3.0% | +1.3% |
| Feb 10, 2025 | ended Dec 2024 | $1.6B (−7% vs a year earlier) | — | −11.2% | −5.9% |
| Oct 28, 2024 | ended Sep 2024 | $1.9B (+2% vs a year earlier) | — | −6.4% | −12.9% |
| Jul 29, 2024 | ended Jun 2024 | $1.5B (0% vs a year earlier) | — | −20.0% | −26.4% |
| Apr 29, 2024 | ended Mar 2024 | $1.4B (−7% vs a year earlier) | — | +5.6% | +5.7% |
| Feb 5, 2024 | ended Dec 2023 | $1.8B (−8% vs a year earlier) | — | −4.0% | −1.6% |
| Oct 30, 2023 | ended Sep 2023 | $1.8B (−13% vs a year earlier) | — | +0.4% | +13.3% |
| Jul 31, 2023 | ended Jun 2023 | $1.5B (−3% vs a year earlier) | — | +0.1% | −3.2% |
| May 1, 2023 | ended Mar 2023 | $1.5B (−8% vs a year earlier) | — | −5.9% | −4.4% |
| Feb 13, 2023 | ended Dec 2022 | $1.9B (+11% vs a year earlier) | — | 0.0% | −10.0% |
| Oct 31, 2022 | ended Sep 2022 | $2.1B (+24% vs a year earlier) | — | −1.5% | +4.0% |
| Aug 1, 2022 | ended Jun 2022 | $1.5B (+7% vs a year earlier) | — | +9.5% | +10.9% |
| May 2, 2022 | ended Mar 2022 | $1.6B (+20% vs a year earlier) | — | −2.4% | −1.2% |
| Feb 14, 2022 | ended Dec 2021 | $1.7B (+26% vs a year earlier) | — | +15.7% | +8.8% |
Change in closing price from the first day shown, or with Price the closing price itself. Prices: Yahoo Finance, to Nov 12, 2026. Dashed lines: the days the company released earnings (its SEC 8-K filings); EPS estimates: Yahoo Finance. The stock's move after a release runs from the last close before its day to the close the day after (or five days after), so a release before the open counts like one after the close.
Is the business growing?
Revenue was $2.0B in the quarter ended Sep 2026, about the same as a year earlier.
Show the data
| Quarter ended | Revenue | vs a year earlier |
|---|---|---|
| Dec 2022 | $1.9B | +11% |
| Mar 2023 | $1.5B | −8% |
| Jun 2023 | $1.5B | −3% |
| Sep 2023 | $1.8B | −13% |
| Dec 2023 | $1.8B | −8% |
| Mar 2024 | $1.4B | −7% |
| Jun 2024 | $1.5B | 0% |
| Sep 2024 | $1.9B | +2% |
| Dec 2024 | $1.6B | −7% |
| Mar 2025 | $1.3B | −3% |
| Jun 2025 | $1.5B | +3% |
| Sep 2025 | $2.0B | +7% |
| Dec 2025 | $1.9B | +16% |
| Mar 2026 | $1.7B | +27% |
| Jun 2026 | $1.9B | +26% |
| Sep 2026 | $2.0B | 0% |
Revenue went from $7.1B in FY22 to $6.7B in FY25; net income from $766M to $374M.
Show the data
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY22 | $7.1B | $766M |
| FY23 | $6.5B | $360M |
| FY24 | $6.3B | $354M |
| FY25 | $6.7B | $374M |
In the fiscal year to Dec 2025, Advanced Products was 83% and Mainstream Products was 17% of revenue; Mainstream Products fell from 23% in the fiscal year to Dec 2023.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2023 | Advanced Products | $5.0B | 77% |
| FY2023 | Mainstream Products | $1.5B | 23% |
| FY2024 | Advanced Products | $5.2B | 82% |
| FY2024 | Mainstream Products | $1.1B | 18% |
| FY2025 | Advanced Products | $5.6B | 83% |
| FY2025 | Mainstream Products | $1.2B | 17% |
In the fiscal year to Dec 2025, United States was 66% and Europe, Middle East and Africa was 13% of revenue; United States rose from 59% in the fiscal year to Dec 2023.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2023 | United States | $3.8B | 59% |
| FY2023 | Europe, Middle East and Africa | $1.0B | 16% |
| FY2023 | Japan | $936M | 14% |
| FY2023 | Asia Pacific (excluding Japan) | $705M | 11% |
| FY2024 | United States | $4.0B | 63% |
| FY2024 | Europe, Middle East and Africa | $818M | 13% |
| FY2024 | Japan | $801M | 13% |
| FY2024 | Asia Pacific (excluding Japan) | $716M | 11% |
| FY2025 | United States | $4.4B | 66% |
| FY2025 | Europe, Middle East and Africa | $853M | 13% |
| FY2025 | Asia Pacific (excluding Japan) | $733M | 11% |
| FY2025 | Japan | $725M | 11% |
A year earlier $0.51
Diluted, from SEC filings
The P/E of 15.0× over the 98% EPS growth of the last four quarters; near 1 or below is cheap for the growth
Quarters: Amkor Technology, Inc.'s SEC filings, named by the month they end. Fiscal years: Amkor Technology, Inc.'s annual reports to the SEC.
How it makes money
Of every $100 in revenue, $5.6 ends up as net income. Net margin fell from 10.8% to 5.6% over the past 3 years.
Show the data
| Quarter ended | Gross | Operating | Net |
|---|---|---|---|
| Dec 2022 | 17.5% | 11.8% | 8.6% |
| Mar 2023 | 13.2% | 4.7% | 3.1% |
| Jun 2023 | 12.8% | 5.2% | 4.4% |
| Sep 2023 | 15.5% | 9.1% | 7.3% |
| Dec 2023 | 15.9% | 9.1% | 6.7% |
| Mar 2024 | 14.8% | 5.4% | 4.3% |
| Jun 2024 | 14.5% | 5.6% | 4.6% |
| Sep 2024 | 14.6% | 8.0% | 6.6% |
| Dec 2024 | 15.1% | 8.3% | 6.5% |
| Mar 2025 | 11.9% | 2.4% | 1.6% |
| Jun 2025 | 12.0% | 6.1% | 3.6% |
| Sep 2025 | 14.3% | 8.0% | 6.4% |
| Dec 2025 | 16.7% | 9.8% | 9.1% |
| Mar 2026 | 14.2% | 6.0% | 4.9% |
| Jun 2026 | 16.8% | 10.5% | 9.2% |
| Sep 2026 | 18.3% | 11.3% | 9.6% |
−4.8 pts over 3 years
−5.7 pts over 3 years
−5.2 pts over 3 years
Each margin is that line of the income statement divided by revenue. Fiscal year: Amkor Technology, Inc.'s annual reports to the SEC; quarters: SEC filings.
Where it is in the chip cycle
Gross margin 18.3% and rising for 2 quarters; inventory at 28 days, up from 21 a year earlier; capital spending 22.4% of revenue over the last 4 quarters.
Show the data
| Period | Inventory days |
|---|---|
| FY22 | 40 |
| FY23 | 26 |
| FY24 | 21 |
| FY25 | 28 |
How many days of sales are sitting in stock. Rising inventory days often come before a downturn: chips are being made faster than they sell.
Show the data
| Period | Capital spending |
|---|---|
| Sep ’25 | 12.4% |
| Dec ’25 | 22.9% |
| Mar ’26 | 13.3% |
| Jun ’26 | 24.4% |
| Sep ’26 | 27.5% |
Money put into factories and equipment. Heavy spending late in an upswing can leave the industry with too much capacity when demand cools.
Gross margin by fiscal quarter, from SEC filings. Inventory days: year-end inventory over that year's cost of revenue, times 365.
Customers and suppliers
In its latest annual report Amkor Technology sells to Apple, Qualcomm; it names no suppliers. Amkor Technology’s blog post names Henkel as a supplier. ASMPT’s press release names Amkor Technology as a customer. Senju Metal Industry’s press release names Amkor Technology as a customer. BE Semiconductor Industries’s annual report for 2025 names Amkor Technology as a customer.
Suppliers
Customers
Their customers
Amkor Technology's 10-K for the year to Dec 2025 gives two customers' shares of its revenue: First Largest Customer (29.8%) and Second Largest Customer (11.1%).
Show the filings' numbers
| Period | Customer | Share of revenue | Filing |
|---|---|---|---|
| Year ended Dec 2023 | First Largest Customer | 27.7% | 10-K filed Feb 20, 2026 |
| Year ended Dec 2024 | First Largest Customer | 30.8% | 10-K filed Feb 20, 2026 |
| Year ended Dec 2024 | Second Largest Customer | 10.2% | 10-K filed Feb 20, 2026 |
| Year ended Dec 2025 | First Largest Customer | 29.8% | 10-K filed Feb 20, 2026 |
| Year ended Dec 2025 | Second Largest Customer | 11.1% | 10-K filed Feb 20, 2026 |
From Amkor Technology, Inc.'s 10-Q and 10-K filings (XBRL): each customer whose share of revenue a filing tags, under the filing's own label, so “Customer A” in one filing can be another company in the next; a later filing's figures for a period replace an earlier one's.
Changes since the previous annual report (10-K filed Feb 21, 2025)
Show the filing's words
| Company | Role | In the filing's words |
|---|---|---|
| Apple | customer | “Direct sales to Apple and Qualcomm accounted for 29.8% and 11.1% of our net sales, respectively, for the year ended December 31, 2025.” |
| Qualcomm | customer | “Direct sales to Apple and Qualcomm accounted for 29.8% and 11.1% of our net sales, respectively, for the year ended December 31, 2025.” |
| ASMPT (press release published Dec 9, 2025) | calls it a customer | “ASMPT has been distinguished with the prestigious Amkor Supplier Excellence Award 2025, underscoring the company’s outstanding performance and long-standing commitment to quality. Selected from a global pool of more than 3,000 suppliers, ASMPT is particularly proud to be the only SMT supplier recognized this year.” |
| Astera Labs (10-K filed Feb 20, 2026) | calls it a supplier | “We also use Advanced Semiconductor Engineering and Amkor Technologies to assemble, package, and test our integrated circuits.” |
| BE Semiconductor Industries (annual report filed Mar 16, 2026) | calls it a customer | “Our customers are primarily leading multinational chip manufacturers, foundries, assembly subcontractors and electronics and industrial companies and include Amkor, ASE, Fabrinet, Forehope, Huatian, Infineon, InnoLight, Intel, LG Innotek, JCET, Luxshare, Nvidia, STMicroelectronics, TDK, Texas Instruments, Tongfu, Unisem and TSMC.” |
| Broadcom (10-K filed Dec 18, 2025) | calls it a supplier | “We use third-party CMs for a significant majority of our assembly and test operations, including TSMC, Advanced Semiconductor Engineering, Inc., Foxconn Technology Group, Amkor Technology, Inc. and Siliconware Precision Industries Co., Ltd.” |
| Credo Technology Group Holding (10-K filed Jun 15, 2026) | calls it a supplier | “•Package, Assembly and Testing: Upon the completion of processing at the foundry, we use third-party contractors for packaging, assembly and testing, including Amkor Technology Inc. (Amkor) and Advanced Semiconductor Engineering, Inc. (ASE) for packaging our IC products, King Yuan Electronics Company (KYEC) and Sigurd Microelectronics Corp. (Sigurd) for testing our IC products and BizLink Technology, Inc. (BizLink) for manufacturing our AEC products.” |
| Qualcomm (10-K filed Nov 4, 2026) | calls it a supplier | “Our primary semiconductor assembly and test suppliers are Amkor Technology, Advanced Semiconductor Engineering, Siliconware Precision Industries and STATS ChipPAC.” |
| Senju Metal Industry (press release published Feb 13, 2026) | calls it a customer | “On December 9, 2025, Senju Metal Industry Co., Ltd. has received the Supplier Excellence Award 2025 from Amkor Technology, Inc. Selected from among more than 3,000 suppliers worldwide, this award recognizes outstanding performance and commitment to quality.” |
| Henkel (blog post published Apr 17, 2025) | supplier | “Amkor’s Robert Lanzone, Corporate VP of System in Package (SiP) BU, presented Henkel Adhesive Technologies with the prestigious Amkor Supplier Award.” |
Only the companies Amkor Technology names in its 10-K filed Feb 20, 2026 (SEC). The supply chain joins the latest annual reports of the companies on it and the 8-Ks they filed since: a link shows when either side's report names the other, so it grows as more reports are read. Also from other documents: Amkor Technology’s blog post, published Apr 17, 2025 (source); ASMPT’s press release, published Dec 9, 2025 (source); Senju Metal Industry’s press release, published Feb 13, 2026 (source); BE Semiconductor Industries’s annual report for 2025, filed Mar 16, 2026 (source). Hover a name for the filing's own words.
Is it expensive?
P/E of 15x, below the peer median of 34.8x, with earnings still growing.
Priced 57% below the peer median of 34.8x.
Show the data
| Company | P/E (trailing) |
|---|---|
| Q · Qnity Electronics, Inc. | 46.1× |
| KLAC · KLA Corporation | 39.4× |
| LRCX · Lam Research Corporation | 34.8× |
| AMAT · Applied Materials, Inc. | 32.9× |
| TER · Teradyne, Inc. | 30.3× |
| AMKR · Amkor Technology, Inc. | 15× |
At 15.0× trailing earnings AMKR is inside the middle of its five-year range; the five-year median is 16.8×.
Show the data
| Date | Trailing P/E |
|---|---|
| Nov 8, 2021 | 10.5× |
| Feb 8, 2022 | 8.3× |
| May 10, 2022 | 6.8× |
| Aug 10, 2022 | 7.7× |
| Nov 8, 2022 | 6.8× |
| Feb 9, 2023 | 9.5× |
| May 11, 2023 | 8.3× |
| Aug 11, 2023 | 11.2× |
| Nov 9, 2023 | 14.0× |
| Feb 12, 2024 | 21.5× |
| May 13, 2024 | 21.5× |
| Aug 13, 2024 | 21.0× |
| Nov 11, 2024 | 18.3× |
| Feb 13, 2025 | 15.5× |
| May 15, 2025 | 15.6× |
| Aug 15, 2025 | 19.3× |
| Nov 13, 2025 | 25.6× |
| Feb 17, 2026 | 31.0× |
| May 18, 2026 | 37.7× |
| Aug 18, 2026 | 24.6× |
| Nov 12, 2026 | 15.0× |
Closing price over diluted earnings per share of the last four reported quarters, as known on each day (a quarter counts 35 days after it ends). From SEC filings; earnings per share adjusted for splits.
What analysts expect
The average analyst price target is $66.00, 78% above the current price; 64% of 11 analysts rate it a buy; earnings beat estimates in 3 of the last 4 quarters.
Buy or Strong Buy: 7 analysts (64%). Sell or Strong Sell: 0.
Over the past year the average of the analysts' latest price targets went from $33.62 to $63.20 (+88%), while AMKR went from $31.95 to $37.12 (+16%). In the past three months targets were cut 5 times and never raised. 1 upgrade and 1 downgrade over the year; the latest: UBS moved it to Buy from Neutral on Jul 25, 2026.
Show every change
| Date | Firm | Change | Rating | Target |
|---|---|---|---|---|
| Nov 9, 2026 | B. Riley Securities | Target cut | Neutral | $38.00, was $41.00 |
| Oct 27, 2026 | B. Riley Securities | Target cut | Neutral | $41.00, was $46.00 |
| Oct 27, 2026 | Morgan Stanley | Target cut | Equal-Weight | $63.00, was $70.00 |
| Oct 27, 2026 | Needham | Target cut | Buy | $55.00, was $90.00 |
| Oct 20, 2026 | B. Riley Securities | Target cut | Neutral | $46.00, was $65.00 |
| Aug 27, 2026 | B of A Securities | Began coverage | Buy | $70.00 |
| Jul 28, 2026 | Morgan Stanley | Target raised | Equal-Weight | $70.00, was $69.00 |
| Jul 28, 2026 | B. Riley Securities | Target cut | Neutral | $65.00, was $75.00 |
| Jul 28, 2026 | Needham | Target kept | Buy | $90.00 |
| Jul 25, 2026 | UBS | Upgrade | Buy, was Neutral | $90.00, was $80.00 |
| Jul 22, 2026 | B. Riley Securities | Target cut | Neutral | $75.00, was $90.00 |
| Jun 25, 2026 | B. Riley Securities | Target raised | Neutral | $90.00, was $70.00 |
| Apr 28, 2026 | B. Riley Securities | Target raised | Neutral | $70.00, was $65.00 |
| Apr 28, 2026 | Goldman Sachs | Target raised | Neutral | $65.00, was $43.00 |
| Apr 28, 2026 | Morgan Stanley | Target raised | Equal-Weight | $69.00, was $45.00 |
| Apr 28, 2026 | Needham | Target raised | Buy | $90.00, was $65.00 |
| Feb 11, 2026 | Goldman Sachs | Target raised | Neutral | $43.00, was $38.00 |
| Feb 10, 2026 | JP Morgan | Target raised | Overweight | $65.00, was $32.00 |
| Feb 10, 2026 | Morgan Stanley | Target raised | Equal-Weight | $45.00, was $28.00 |
| Feb 10, 2026 | Needham | Target raised | Buy | $65.00, was $50.00 |
| Jan 15, 2026 | B. Riley Securities | Target raised | Neutral | $48.00, was $29.00 |
| Jan 12, 2026 | UBS | Downgrade | Neutral, was Buy | $55.00, was $38.00 |
| Jan 5, 2026 | Needham | Target raised | Buy | $50.00, was $37.00 |
Show the data
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec ’25 | $0.44 | $0.69 | +56.8% |
| Mar ’26 | $0.24 | $0.33 | +37.5% |
| Jun ’26 | $0.48 | $0.70 | +45.8% |
| Sep ’26 | $0.78 | $0.76 | −2.6% |
The day after each of these reports the stock moved +8.3% (Dec 2025, beat); −8.6% (Mar 2026, beat); −29.7% (Jun 2026, beat); +1.6% (Sep 2026, missed).
For the quarter ending Dec 2026, analysts expect adjusted earnings of $0.72 a share, and revenue of $2.0B, up 4% on a year earlier. For the fiscal year ending Dec 2027, they expect adjusted earnings of $2.78 a share, 11% more than the year before's estimate of $2.50, and revenue of $8.6B, up 14% on the year before's estimate.
Adjusted. Dec 2025: $0.69, far from its estimate; range $0.70 to $0.78; 8 analysts
Dec 2025: $1.9B; range $1.9B to $2.0B; 8 analysts
Adjusted. The year to Dec 2026: $2.50 expected; range $2.25 to $3.80; 9 analysts
The year to Dec 2026: $7.5B expected; range $8.3B to $9.2B; 11 analysts
Show the data
| Period | Figure | Expected | Low to high | Analysts | A year earlier | Change |
|---|---|---|---|---|---|---|
| Quarter ending Dec 2026 | EPS (adjusted) | $0.72 | $0.70 to $0.78 | 8 | $0.69 (Dec 2025) | — |
| Quarter ending Dec 2026 | Revenue | $2.0B | $1.9B to $2.0B | 8 | $1.9B (Dec 2025) | +4% |
| Quarter ending Mar 2027 | EPS (adjusted) | $0.54 | $0.31 to $0.77 | 8 | $0.33 (Mar 2026) | +65% |
| Quarter ending Mar 2027 | Revenue | $1.9B | $1.7B to $2.0B | 7 | $1.7B (Mar 2026) | +13% |
| Year ending Dec 2026 | EPS (adjusted) | $2.50 | $2.49 to $2.52 | 8 | — | — |
| Year ending Dec 2026 | Revenue | $7.5B | $7.5B to $7.6B | 9 | $6.7B (year to Dec 2025) | +12% |
| Year ending Dec 2027 | EPS (adjusted) | $2.78 | $2.25 to $3.80 | 9 | $2.50 (expected, year to Dec 2026) | +11% |
| Year ending Dec 2027 | Revenue | $8.6B | $8.3B to $9.2B | 11 | $7.5B (expected, year to Dec 2026) | +14% |
Targets, ratings and earnings estimates: Yahoo Finance. Rating and target changes: Yahoo Finance's list of upgrades and downgrades. The average target on each day is the average of every listed firm's latest target set in the 180 days before it, so it counts fewer analysts than the average target above, and the band is the middle half of those targets (a quarter of the firms are above it, a quarter below); a target set before a stock split is divided by the split. Expected figures: the average of the analysts' estimates (Yahoo Finance). Their EPS is adjusted, as analysts estimate it, so it is set against the adjusted EPS Yahoo reports for the same quarters, not the GAAP EPS of the growth and valuation sections; revenue against the SEC filings. No change is given against a quarter whose reported EPS was more than 50% off its own estimate (often a one-off gain or charge), nor against a year that counts one. Each estimate is pinned to its fiscal period by the report date or the period's end, and one that cannot be is left out.
Where the cash goes
Capex of $1.7B exceeds operating cash flow of $1.5B, leaving free cash flow of −$160M. It still paid $80M to shareholders (dividends plus buybacks), so $240M had to come from cash on hand or borrowing.
Show the data
| Line | Amount |
|---|---|
| Op. cash flow | $1.5B |
| Capex | −$1.7B |
| Free cash flow | −$160M |
| Dividends | −$80M |
| Buybacks | — |
| Cash retained | −$240M |
Free cash flow is negative, so the company is burning cash.
For every $100 of market cap, you receive about $0.9 in dividends a year.
Show the data
| Quarter ended | Free cash flow | Dividends | Buybacks |
|---|---|---|---|
| Dec 2023 | $336M | $19M | — |
| Mar 2024 | $66M | $19M | — |
| Jun 2024 | $58M | $19M | — |
| Sep 2024 | −$31M | $19M | — |
| Dec 2024 | $252M | $120M | — |
| Mar 2025 | −$56M | $0 | — |
| Jun 2025 | $112M | $41M | — |
| Sep 2025 | −$78M | $20M | — |
| Dec 2025 | $212M | $21M | — |
| Mar 2026 | −$80M | $21M | — |
| Jun 2026 | −$227M | $21M | — |
| Sep 2026 | −$62M | $21M | — |
Amkor Technology had 250M diluted shares in the quarter ended Sep 2026, 0.5% more than a year earlier, and 0.5% more each year on average since Jun 2020. Over the last four quarters its earnings per share rose 98.4% and its net income rose 101.3%: more shares took about 3 points off.
Show the data
| Quarter ended | Diluted shares |
|---|---|
| Jun 2020 | 241M |
| Sep 2020 | 243M |
| Mar 2021 | 245M |
| Jun 2021 | 246M |
| Sep 2021 | 246M |
| Mar 2022 | 246M |
| Jun 2022 | 246M |
| Sep 2022 | 246M |
| Mar 2023 | 247M |
| Jun 2023 | 247M |
| Sep 2023 | 247M |
| Mar 2024 | 248M |
| Jun 2024 | 248M |
| Sep 2024 | 248M |
| Mar 2025 | 248M |
| Jun 2025 | 248M |
| Sep 2025 | 248M |
| Mar 2026 | 250M |
| Jun 2026 | 250M |
| Sep 2026 | 250M |
Free cash flow: operating cash flow minus capital spending on property, plant and equipment, from SEC filings, for the last 4 quarters and by quarter. Shares: each quarter's diluted weighted average as filed with the SEC, since the stock's listing and its latest split.
Financial health
Current ratio 2.3, no pressure to repay short-term debt; debt-to-equity 0.3, debt is very low and the balance sheet is solid.
Assets that can be turned into cash soon are 2.3x what is owed within a year. 1.5 or higher is comfortable; below 1 needs watching.
For every $1 of shareholder funds, there is $0.3 of debt (leases not counted). The higher the number, the more pressure when the economy weakens.
Cash and short-term investments of $2.0B against debt of $1.4B. Lease obligations of $116M are not counted: they are rent owed, not money borrowed.
Latest fiscal year balance sheet. Source: Yahoo Finance.
Who holds it
In the filings of 8 funds whose copy leaves AMKR out (on the exchange, not in the app yet): Light Street Capital Management, Fisher Asset Management, Norges Bank, Swiss National Bank, Maverick Capital, Mirae Asset Global Investments and 2 more.
What did the funds Hunch tracks do?
Of the 83 funds whose 13F filings Hunch reads, 11 held AMKR at the end of their latest quarter (for most, Q2 2026). Over that quarter 5 added shares, 3 cut and 3 bought new. The largest of them is Norges Bank, 1.48M shares worth $127M at Jun 30, 2026, 8.6% more than at Dec 31, 2025.
3 of them new holders
Over their latest quarter
Show every fund
| Fund | Quarter | Shares | Value | Change in shares | Change | Filed |
|---|---|---|---|---|---|---|
| Norges Bank | Q2 2026 vs Q4 2025 | 1.48M | $127M | +117,007 | +8.6% | Aug 12, 2026 |
| Fisher Asset Management | Q3 2026 | 2.00M | $105M | +179,577 | +9.9% | Nov 6, 2026 |
| Light Street Capital Management | Q2 2026 | 596,783 | $51.5M | +189,793 | +47% | Aug 14, 2026 |
| Renaissance Technologies | Q3 2026 | 338,700 | $17.7M | −241,900 | −42% | Nov 12, 2026 |
| Swiss National Bank | Q3 2026 | 250,600 | $13.1M | +2,000 | +0.8% | Nov 12, 2026 |
| Tudor Investment Corp Et Al | Q2 2026 | 106,660 | $9.2M | −194,210 | −65% | Aug 14, 2026 |
| Canada Pension Plan Investment Board | Q2 2026 | 80,300 | $6.9M | +80,300 | New | Aug 14, 2026 |
| Nomura Holdings | Q2 2026 | 43,844 | $3.8M | +43,844 | New | Aug 14, 2026 |
| Mirae Asset Global Investments | Q3 2026 | 62,273 | $3.3M | +4,072 | +7.0% | Nov 3, 2026 |
| Maverick Capital | Q2 2026 | 8,860 | $764K | +8,860 | New | Aug 14, 2026 |
| Bridgewater Associates | Q2 2026 | 7,145 | $616K | −1.57M | −100% | Aug 14, 2026 |
From the 13F filings of the 83 funds Hunch tracks, not of every institution: each fund's shares of AMKR at its latest quarter end against the quarter before, as filed (long positions only, options left out), the quarter before put on the latest quarter's share count across a split. A fund files 45 days after its quarter ends, so some have a newer quarter than others. Value is at the quarter end. Norges Bank filed its 13F for Q1 2026 confidentially, with no holdings made public, so its row compares Q2 2026 with Q4 2025.
Are insiders buying or selling?
Officers and directors sold $22.4M of AMKR on the open market in the 12 months to Nov 10, 2026; none bought. 29% of the sales were made under 10b5-1 plans, set up in advance. The largest was Guillaume Marie Jean Rutten (Director), who sold $9.2M in 8 sales.
41 sales
0 purchases
Share of the sales' value
Show every trade
| Date | Insider | Role | Trade | Shares | Price | Value | Filed |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Kevin K. Engel | President and CEO; director | Sale (10b5-1 plan) | 1,000 | $35.00 | $35K | Nov 10, 2026 |
| Oct 13, 2026 | Megan Faust | CFO | Sale (10b5-1 plan) | 1,000 | $46.92 | $47K | Oct 15, 2026 |
| Oct 2, 2026 | Douglas A Alexander | Director | Sale (10b5-1 plan) | 5,000 | $55.00 | $275K | Oct 6, 2026 |
| Sep 8, 2026 | Megan Faust | CFO | Sale (10b5-1 plan) | 1,000 | $49.05 | $49K | Sep 10, 2026 |
| Aug 17, 2026 | Mark N Rogers | EVP & General Counsel | Sale (10b5-1 plan) | 5,000 | $59.78 | $299K | Aug 19, 2026 |
| Aug 11, 2026 | Megan Faust | CFO | Sale (10b5-1 plan) | 1,000 | $54.45 | $54K | Aug 13, 2026 |
| Aug 7, 2026 | Douglas A Alexander | Director | Sale (10b5-1 plan) | 5,000 | $55.81 | $279K | Aug 11, 2026 |
| Aug 6, 2026 | Guillaume Marie Jean Rutten | Director | Sale | 25,000 | $54.50 | $1.4M | Aug 7, 2026 |
| Aug 5, 2026 | Guillaume Marie Jean Rutten | Director | Sale | 25,000 | $55.35 | $1.4M | Aug 7, 2026 |
| Jul 30, 2026 | Kevin K. Engel | President and CEO; director | Sale | 3,221 | $47.00 | $151K | Jul 31, 2026 |
| Jul 16, 2026 | Mark N Rogers | EVP & General Counsel | Sale (10b5-1 plan) | 5,000 | $65.12 | $326K | Jul 20, 2026 |
| Jul 14, 2026 | Megan Faust | CFO | Sale (10b5-1 plan) | 1,000 | $69.91 | $70K | Jul 16, 2026 |
| Jun 16, 2026 | Mark N Rogers | EVP & General Counsel | Sale (10b5-1 plan) | 5,000 | $86.21 | $431K | Jun 18, 2026 |
| Jun 12, 2026 | Winston J Churchill | Director | Sale | 5,000 | $78.20 | $391K | Jun 16, 2026 |
| Jun 9, 2026 | Megan Faust | CFO | Sale (10b5-1 plan) | 1,000 | $70.30 | $70K | Jun 11, 2026 |
| May 19, 2026 | Megan Faust | CFO | Sale (10b5-1 plan) | 1,000 | $64.60 | $65K | May 20, 2026 |
| May 18, 2026 | Mark N Rogers | EVP & General Counsel | Sale (10b5-1 plan) | 5,000 | $71.63 | $358K | May 20, 2026 |
| May 11, 2026 | Gil C. Tily | Director | Sale | 15,000 | $77.30 | $1.2M | May 13, 2026 |
| May 8, 2026 | Guillaume Marie Jean Rutten | Director | Sale | 50,000 | $74.28 | $3.7M | May 12, 2026 |
| May 5, 2026 | Douglas A Alexander | Director | Sale | 4,657 | $76.58 | $357K | May 7, 2026 |
| May 5, 2026 | Douglas A Alexander | Director | Sale | 343 | $76.58 | $26K | May 7, 2026 |
| May 5, 2026 | Winston J Churchill | Director | Sale | 7,000 | $76.45 | $535K | May 7, 2026 |
| May 5, 2026 | Roger Anthony Carolin | Director | Sale | 20,000 | $76.24 | $1.5M | May 7, 2026 |
| Apr 16, 2026 | Mark N Rogers | EVP & General Counsel | Sale (10b5-1 plan) | 5,000 | $59.43 | $297K | Apr 20, 2026 |
| Mar 16, 2026 | Mark N Rogers | EVP & General Counsel | Sale (10b5-1 plan) | 5,000 | $44.54 | $223K | Mar 18, 2026 |
| Feb 25, 2026 | Farshad Haghighi | Executive Vice President | Sale | 15,624 | $50.50 | $789K | Feb 26, 2026 |
| Feb 24, 2026 | Guillaume Marie Jean Rutten | Director | Sale | 20,000 | $48.80 | $976K | Feb 26, 2026 |
| Feb 24, 2026 | Kevin K. Engel | President and CEO; director | Sale | 12,500 | $48.75 | $609K | Feb 26, 2026 |
| Feb 17, 2026 | Mark N Rogers | EVP & General Counsel | Sale (10b5-1 plan) | 5,000 | $46.92 | $235K | Feb 18, 2026 |
| Feb 17, 2026 | Kevin K. Engel | President and CEO; director | Sale | 5,316 | $46.03 | $245K | Feb 18, 2026 |
| Feb 17, 2026 | Guillaume Marie Jean Rutten | Director | Sale (10b5-1 plan) | 10,000 | $45.89 | $459K | Feb 18, 2026 |
| Jan 16, 2026 | Mark N Rogers | EVP & General Counsel | Sale (10b5-1 plan) | 5,000 | $49.28 | $246K | Jan 20, 2026 |
| Jan 15, 2026 | Guillaume Marie Jean Rutten | Director | Sale (10b5-1 plan) | 10,000 | $53.14 | $531K | Jan 20, 2026 |
| Dec 16, 2025 | Mark N Rogers | EVP & General Counsel | Sale (10b5-1 plan) | 20,000 | $42.95 | $859K | Dec 17, 2025 |
| Dec 15, 2025 | Guillaume Marie Jean Rutten | President and CEO; director | Sale (10b5-1 plan) | 10,000 | $44.80 | $448K | Dec 17, 2025 |
| Dec 15, 2025 | Winston J Churchill | Director | Sale | 5,000 | $44.29 | $221K | Dec 17, 2025 |
| Dec 12, 2025 | Gil C. Tily | Director | Sale | 20,000 | $46.44 | $929K | Dec 16, 2025 |
| Dec 12, 2025 | Kevin Engel | Executive Vice President | Sale | 11,000 | $46.21 | $508K | Dec 16, 2025 |
| Dec 12, 2025 | MaryFrances McCourt | Director | Sale | 20,000 | $46.02 | $920K | Dec 16, 2025 |
| Nov 17, 2025 | Mark N Rogers | EVP & General Counsel | Sale (10b5-1 plan) | 20,000 | $31.69 | $634K | Nov 19, 2025 |
| Nov 17, 2025 | Guillaume Marie Jean Rutten | President and CEO; director | Sale (10b5-1 plan) | 10,000 | $31.68 | $317K | Nov 19, 2025 |
From the Form 4s filed with the SEC about Amkor Technology, Inc. (138 in the 12 months): purchases (code P) and sales (code S) on the open market by its officers and directors, at the price each filing gives (often an average of the day's trades). A sale is a 10b5-1 sale when its filing says it was made under such a plan, set up in advance. Not counted: 144 other transactions (grants, option exercises, shares withheld for tax and gifts). Also not counted: 2 trades by holders of more than 10% who are neither officers nor directors.